Robert Hsu

Title(s)Assistant Professor of Clinical Medicine
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave. NTT3440
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard
    Other Positions
    Title(s)Director of LAC Lung Medical Oncology


    Collapse Biography 
    Collapse education and training
    Cornell University, Ithaca, NYBS2009Biological Sciences & Biometry & Statistics
    University of Toledo, Toledo, OHMS2012Biomedical Sciences
    Tulane University School of Medicine, New Orleans, LAMD2016
    University of Miami/Jackson Memorial Hospital, Miami, FL2019Residency, Internal Medicine
    University of Southern California, Los Angeles, CA2022Fellowship, Hematology & Oncology
    Collapse awards and honors
    National Institutes of Health2007NIH Summer Student Intramural Award
    Cornell University2008Cornell University Community Partnership Grant
    Cornell University2009Cum Laude Distinction
    AmeriCorps2010  - 2011AmeriCorps Segal Education Award
    Tulane University School of Medicine2014Southern Section-American Federation for Clinical Research Travel Award
    2017Asian Pacific American Medical Student President’s Award for Distinguished Service
    2018Summit on National and Global Cancer Health Disparities Travel Award
    University of Southern California2021  - 2022Best Research Award at USC Medical Oncology Fellows Research Symposium
    International Association for the Study of Lung Cancer2024Academy Award

    Collapse Overview 
    Collapse overview
    Dr. Robert Hsu is an Assistant Professor of Medicine in the Division of Medical Oncology at University of Southern California focusing on thoracic cancers. Dr. Hsu completed his medical school training at Tulane University School of Medicine followed by Internal Medicine residency training at University of Miami/Jackson Memorial and then hematology and oncology training at Los Angeles County+University of Southern California where he served as chief fellow for medical oncology.

    His research interests are focused in lung cancer research along with cancer disparities across multiple solid tumor types. His research includes projects involving comprehensive genomic profiling looking at biomarkers in lung cancer, retrospective database work looking at lung cancer patients treated at USC looking at mutation differences among different ethnicities particularly Hispanics, epidemiological research looking at lung and thyroid cancer incorporating the California Cancer Registry, and translational research looking at tumor microenvironment and ethnicities in lung and breast cancer.

    Collapse Research 
    Collapse research activities and funding
    A phase II study of subcutaneous atezolizumab in NSCLC patients using a decentralized clinical trial model
    Robert A. Winn Excellence in Clinical Trials Career Development Award Oct 1, 2024 - Jan 1, 2027

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impact of Modern Systemic Therapies on Survival in Patients with Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Review. Drugs Real World Outcomes. 2025 May 16. Luong A, Poei D, Chow L, Li M, Nie Q, Angell T, Tang L, Hsu R, Thomas J. PMID: 40379918.
      View in: PubMed   Mentions:
    2. Advances in adoptive cell therapies in small cell lung cancer. Explor Target Antitumor Ther. 2025; 6:1002302. Bragasin EI, Cheng J, Ford L, Poei D, Ali S, Hsu R. PMID: 40160238; PMCID: PMC11949692.
      View in: PubMed   Mentions:
    3. Gender and Geographic Characteristics Among Thoracic, GI, and Breast Oncology Editorial Boards: Disparities and Measures to Address Gaps. JCO Glob Oncol. 2025 Feb; 11:e2400656. Hsu R, Arter ZL, Benjamin DJ. PMID: 40014842.
      View in: PubMed   Mentions:    Fields:    
    4. Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road. Transl Cancer Res. 2025 Feb 28; 14(2):679-684. Hsu R. PMID: 40104722; PMCID: PMC11912053.
      View in: PubMed   Mentions:
    5. Real-World Incidence of Anaplastic Lymphoma Kinase Alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles. Cancer Res Commun. 2025 Feb 01; 5(2):277-286. Poei D, Ali S, Thomas JS, Nieva JJ, Hsu RC. PMID: 39807831; PMCID: PMC11808653.
      View in: PubMed   Mentions:    Fields:    
    6. Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy. Front Oncol. 2024; 14:1457006. Benjamin DJ, Hsu RC. PMID: 39882447; PMCID: PMC11774724.
      View in: PubMed   Mentions:
    7. The current landscape and prospects of antibody-drug conjugates for lung cancer brain metastases: a narrative review. Transl Lung Cancer Res. 2024 Dec 31; 13(12):3778-3794. Zhou H, Zeng Y, Hida T, Hsu R, Huang Y, Dong X. PMID: 39830739; PMCID: PMC11736593.
      View in: PubMed   Mentions:
    8. Assessing the predictive role of platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: an analysis across TKI generations. Discov Oncol. 2024 Nov 21; 15(1):689. Cooper R, Ramaswami D, Thomas JS, Nieva JJ, Hsu R. PMID: 39570469; PMCID: PMC11582238.
      View in: PubMed   Mentions:
    9. Addressing the unmet need in NSCLC progression with advances in second-line therapeutics. Explor Target Antitumor Ther. 2024; 5(6):1297-1320. Wang K, Leyba A, Hsu R. PMID: 39759220; PMCID: PMC11700623.
      View in: PubMed   Mentions:
    10. Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions. Antibodies (Basel). 2024 Oct 18; 13(4). Wang K, Hsu R. PMID: 39449330; PMCID: PMC11503282.
      View in: PubMed   Mentions: 1  
    11. A narrative review on perioperative systemic therapy in non-small cell lung cancer. Explor Target Antitumor Ther. 2024; 5(4):931-954. Hsu R, Arter ZL, Poei D, Benjamin DJ. PMID: 39280253; PMCID: PMC11390295.
      View in: PubMed   Mentions: 2  
    12. ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies. Cancer Drug Resist. 2024; 7:20. Poei D, Ali S, Ye S, Hsu R. PMID: 38835344; PMCID: PMC11149099.
      View in: PubMed   Mentions: 4  
    13. A narrative review of the efficacy and safety FDA-approved antibody-drug conjugates in older patients. AME Medical Journal. 2024. Hsu R, Nieva JJ. View Publication.
    14. Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer. Breast Cancer Res Treat. 2024 Jul; 206(2):245-259. Hsu R, Al-Zubeidy B, Flores D, Nazarian A, Baugh A, Gonzalez E, Castanon S, Xiu J, Kang I, Spicer D, Lenz HJ, Dara L, Ademuyiwa FO, Korn WM, Irshad S, Chan IS, Roussos Torres ET. PMID: 38643348; PMCID: PMC11182800.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020. Cancers (Basel). 2024 Mar 08; 16(6). Hsu RC, Tsai KY, Benjamin DJ, Chennapan K, Wojcik KY, Lee AW, Thomas JS, Nieva JJ, Liu L. PMID: 38539437; PMCID: PMC10969047.
      View in: PubMed   Mentions:
    16. Cost effectiveness of immunotherapy combination therapies for endometrial cancer. Gynecol Oncol Rep. 2024 Apr; 52:101351. Benjamin DJ, Padula WV, Hsu RC. PMID: 38449799; PMCID: PMC10915342.
      View in: PubMed   Mentions:
    17. A narrative review of antibody-drug conjugates in EGFR-mutated non-small cell lung cancer. Front Oncol. 2023; 13:1252652. Hsu R, Benjamin DJ. PMID: 38107063; PMCID: PMC10722249.
      View in: PubMed   Mentions: 1  
    18. Complete response with pembrolizumab in recurrent squamous cell carcinoma of the oral tongue: A case report. Oral Oncol. 2023 Dec; 147:106597. Cheng JY, Hsu RC, Nieva JJ, Thomas JS. PMID: 37857230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer. Front Oncol. 2023; 13:1215524. Hsu R, Chen D, Xia B, Feldman R, Cozen W, Raez LE, Borghaei H, Kim C, Nagasaka M, Mamdani H, Vanderwalde AM, Lopes G, Socinski MA, Wozniak AJ, Spira AI, Liu SV, Nieva JJ. PMID: 37700839; PMCID: PMC10494442.
      View in: PubMed   Mentions:
    20. Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy. Front Immunol. 2023; 14:1258388. Benjamin DJ, Hsu R. PMID: 37675102; PMCID: PMC10477976.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer. Cancer Treat Res Commun. 2023; 36:100752. MacDonald M, Poei D, Leyba A, Diep R, Chennapan K, Leon C, Xia B, Nieva JJ, Hsu R. PMID: 37611343; PMCID: PMC11160511.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    22. The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review. Cancers (Basel). 2023 Jul 10; 15(14). Hsu R, Benjamin DJ, Nagasaka M. PMID: 37509224; PMCID: PMC10377299.
      View in: PubMed   Mentions: 7  
    23. A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer. Clin Lung Cancer. 2023 05; 24(3):228-234. Iams WT, Balbach ML, Phillips S, Sacher A, Bestvina C, Velcheti V, Wang X, Marmarelis ME, Sethakorn N, Leal T, Sackstein PE, Kim C, Robinson MA, Mehta K, Hsu R, Nieva J, Patil T, Camidge DR. PMID: 36841727; PMCID: PMC10234144.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Characterization of mortality and high-risk characteristics of thyroid cancer in Filipinos using the California Cancer Registry. Front Public Health. 2022; 10:1104607. Hsu R, Tsai KY, Chennapan K, Wojcik KY, Lee AW, Nieva JJ, Liu L. PMID: 36743179; PMCID: PMC9893642.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. Clin Cancer Res. 2022 09 15; 28(18):4092-4104. Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent JC, Ravi V, Patel S, Wilky BA. PMID: 35180772; PMCID: PMC9475245.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    26. Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles. Clin Lung Cancer. 2022 11; 23(7):e443-e452. Hsu R, Herrmann A, Gaur K, Xia B, Nieva JJ. PMID: 35902325.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas. Oncotarget. 2021 Dec 07; 12(25):2449-2458. Hsu R, Baca Y, Xiu J, Wang R, Bodor JN, Kim C, Khan H, Mamdani H, Nagasaka M, Puri S, Liu SV, Korn WM, Nieva JJ. PMID: 34917263; PMCID: PMC8664394.
      View in: PubMed   Mentions: 6     Fields:    
    28. Thyroid cancer incidence disparities among ethnic Asian American populations, 1990-2014. Ann Epidemiol. 2022 02; 66:28-36. Lee AW, Mendoza RA, Aman S, Hsu R, Liu L. PMID: 34774744.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    29. The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer. JTO Clin Res Rep. 2021 Jul; 2(7):100194. Gitlitz BJ, Novello S, Vavalà T, Bittoni M, Sable-Hunt A, Pavlick D, Hsu R, Park SL, Chen R, Cooke M, Moore A, Schrock AB, Schiller JH, Addario BJ, Oxnard GR. PMID: 34590039; PMCID: PMC8474359.
      View in: PubMed   Mentions: 7  
    30. The effects of high impact exercise intervention on bone mineral density, physical fitness, and quality of life in postmenopausal women with osteopenia: A retrospective cohort study. Medicine (Baltimore). 2019 Mar; 98(11):e14898. Yu PA, Hsu WH, Hsu WB, Kuo LT, Lin ZR, Shen WJ, Hsu RW. PMID: 30882707; PMCID: PMC6426501.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    31. Methodological evaluation of the noninvasive estimation of central systolic blood pressure in nontreated patients: the Bogalusa Heart Study. Blood Press Monit. 2017 Apr; 22(2):95-100. Fernandez C, Hsu R, Sander G, Hussain A, Barshop R, Li S, Shu T, Zhang T, Galazka P, Chen W, Bazzano L, Giles TD. PMID: 27902495; PMCID: PMC7528040.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Novel Pathophysiological Mechanisms in Hypertension. Adv Exp Med Biol. 2017; 956:21-35. Samson R, Lee A, Lawless S, Hsu R, Sander G. PMID: 27981434.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    33. Chagas Cardiomyopathy in New Orleans and the Southeastern United States. Ochsner J. 2016; 16(3):304-8. Hsu RC, Burak J, Tiwari S, Chakraborti C, Sander GE. PMID: 27660581; PMCID: PMC5024814.
      View in: PubMed   Mentions: 3  
    34. Abstracts of the 56th Annual Scientific Meeting of the Society for Gynecologic Investigation. March 17-21, 2009. Reprod Sci. 2009 Mar; 16(3 Suppl):69A-374A. PMID: 20086269.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    Robert's Networks
    Concepts (79)
    Derived automatically from this person's publications.
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _